Autopsy report · NCT04082000
Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy
Cause of deathFunding or business
“study stopped due to company strategic prioritization”
Life of this trial
- Registered 5 months after it had already started.
- Ran for about 1 year 7 months before it stopped.
- 2 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Breath of Life International Pharma Ltd
- Sponsor type
- Industry
- Conditions
- Diabetic Neuropathy
- Interventions
- BOL-DP-o-04; Placebo
- Participants
- 2
- Sites
- 1
- Countries
- Israel
Trials that died the same way
- Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
“The study was stopped due to a realignment of strategic priorities” - Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma
“Company decision not to start the study” - Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
“Study stopped following management decision” - Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®
“This study has been cancelled before initiation due to company's prioritisation decisions linked to resources restrictions.” - A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis
“The study was terminated due to strategic business reasons.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.